MICHAEL M. TARNOW

Insider Reports History

Signature
/s/ Cassandra Robinson, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MICHAEL M. TARNOW:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. Director Common Shares 77,942 $767,729 $9.85 18 May 2021 Direct
Xenon Pharmaceuticals Inc. Director Stock Option (Right to Buy) 0 18 May 2021 Direct

Insider Reports Filed by MICHAEL M. TARNOW

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XENE Xenon Pharmaceuticals Inc. 18 May 2021 6 +$30,612 4 Director 20 May 2021, 16:18